CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


18F-αvβ6-BPWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D007239 Infection NIH 0.07

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 18F-αvβ6-binding-peptide PET/CT in Patients Post SARS CoV2 Infection

This is a PET/CT study using the 18F-αvβ6-binding-peptide.The goal of this study is to evaluate this peptide in patients after infection with SARS CoV2.

NCT04376593 COVID-19 SARS-CoV-2 Infection Drug: 18F-αvβ6-BP
MeSH:Infection

Primary Outcomes

Description: Completion of administration of 18F-αvβ6-BP in SARC CoV2 patients

Measure: Administration of 18F-αvβ6-BP

Time: baseline

Description: Completion of administration of 18F-αvβ6-BP in SARC CoV2 patients

Measure: Administration of 18F-αvβ6-BP

Time: 3 months

Description: Completion of administration of 18F-αvβ6-BP in SARC CoV2 patients

Measure: Administration of 18F-αvβ6-BP

Time: 6 months

Secondary Outcomes

Description: Uptake of 18F-αvβ6-BP in lung damage will be measured by PET

Measure: Determine whether 18F-αvβ6-BP demonstrates accumulation in lung damage

Time: baseline

Description: Uptake of 18F-αvβ6-BP in lung damage will be measured by PET

Measure: Determine whether 18F-αvβ6-BP demonstrates accumulation in lung damage

Time: 3 months

Description: Uptake of 18F-αvβ6-BP in lung damage will be measured by PET

Measure: Determine whether 18F-αvβ6-BP demonstrates accumulation in lung damage

Time: 6 months

Other Outcomes

Description: Uptake of 18F-αvβ6-BP in lung measured by PET will be compared to lung damage as indicated on CT.

Measure: Determine whether 18F-αvβ6-BP accumulation in lung correlates to lung damage as indicated on CT.

Time: baseline

Description: Uptake of 18F-αvβ6-BP in lung measured by PET will be compared to lung damage as indicated on CT.

Measure: Determine whether 18F-αvβ6-BP accumulation in lung correlates to lung damage as indicated on CT.

Time: 3 months

Description: Uptake of 18F-αvβ6-BP in lung measured by PET will be compared to lung damage as indicated on CT.

Measure: Determine whether 18F-αvβ6-BP accumulation in lung correlates to lung damage as indicated on CT.

Time: 6 months


No related HPO nodes (Using clinical trials)